The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world's largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.

The University of Oxford's Social Sciences Division will host the Social Sciences Impact Conference on 24-25 March 2026 at St Anne's College, Oxford - bringing together researchers, policymakers, practitioners and innovators to explore how social science can help address complex challenges and deliver meaningful change. The 2026 conference theme, Impact in Motion: Navigating Uncertainty, Creating Change , will examine how collaboration, openness, innovation and inclusion can help societies respond constructively in a rapidly changing world.

Two companion studies, published in Cell Genomics , reveal how brain development lays the foundation for both shared and sex-specific circuits, redefining how neural diversity arises. A preview article l'inked to the report highlights the broader significance of these findings and places them in context for the field.

Professor Rebecca Eynon , Professor of Education, the Internet and Society, in the Department of Education and Oxford Internet Institute , is among the outstanding social scientists elected to the fellowship of the Academy of Social Sciences today.

The World Health Organization (WHO) has designated the Nuffield Department of Primary Care Health Sciences at the University of Oxford as the WHO Collaborating Centre on Primary Health Care.

Researchers from the University of Oxford have been presented The Queen Elizabeth Prizes for Higher and Further Education in recognition of outstanding work at UK universities and colleges in a ceremony at St James's Palace.

The Stephen A. Schwarzman Centre , a new world-class centre for the Arts and Humanities in Oxford, will launch its public programme on 25 April 2026 with a day of free events and performances. The new academic and cultural centre provides a unique mix of exceptional performance and research spaces alongside academic teaching facilities. 

An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.